Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on insulin-induced responses in MCF-7 human breast cancer cells

Toxicology and Applied Pharmacology

Volumn 138, Issue 2, 1996, Pages 242-250

  Liu, Hong ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,3,7,8 TETRACHLORODIBENZOFURAN; ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; INSULIN; INSULIN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; HUMAN; HUMAN CELL; RECEPTOR BINDING;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030175873     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0122     Document Type: Article

References (79)

1. Araki, E. F., Shimada, F., Uzawa, A., Mori, M., and Ebina, Y. (1987). Characterization of the promoter region of the human insulin receptor gene: Evidence for promoter activity. J. Biol. Chem. 262, 16186-16191.
2. Astroff, B., and Safe, S. (1988). Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat. Toxicol. Appl. Pharmacol. 95, 435-443.
3. Biegel, L., and Safe, S. (1990). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 37, 725-732.
4. Bombick, D. W., Jankun, J., Tullis, K., and Matsumura, F. (1988). 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyro sine kinases in selected tissues of responsive mouse strains. Proc. Natl Acad. Sci. USA 85, 4128-4132.
5. Briata, P., and Gherzi, R. (1990). Multifactorial control of insulin receptor gene expression in human cell lines. Biochem. Biophys. Res. Commun. 170, 1184-1190.
6. Briata, P., Briata, L., and Gherzi, R. (1990). Glucose starvation and glycosylation inhibitors reduce insulin receptor gene expression: Characterization and potential mechanism in human cells. Biochem. Biophys. Res. Commun. 169, 397-405.
7. Butler, W. B., Kelsey, W. H., and Goran, N. (1981). Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens. Cancer Res. 41, 82-88.
8. DeVito, M. J., Ma, X., Babish, J. G., Menache, M., and Birnbaum, L. S. (1994). Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation. Toxicol. Appl. Pharmacol. 124, 82-90.
9. Dickson, R. B., and Lippman, M. E. (1986). Hormonal control of human breast cancer cell lines. Cancer Surv. 5, 617-624.
10. Dubik, D., Dembinski, T. C., and Shiu, R. P. C. (1987). Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res. 47, 6517-6521.
11. Ebner, K., Matsumura, F., Enan, E., and Olsen, H. (1993). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters pancreatic membrane tyrosine phosphorylation following acute treatment. J. Biochem. Toxicol. 8, 71-81.
12. Enan, E., and Matsumura, F. (1993). 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced alterations in protein phosphorylation in guinea pig adipose tissue. J. Biochem. Toxicol. 8, 89-99.
13. Fernandez, P., and Safe, S. (1992). Growth inhibitory and antimitogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells. Toxicol. Lett. 61, 185-197.
14. Freiss, G., Prébois, C., and Vignon, F. (1993). Control of breast cancer cell growth by steroids and growth factors: Interactions and mechanisms. Breast Cancer Res. Treat. 27, 57-68.
15. Gierthy, J. F., and Lincoln, D. W. (1988). Inhibition of postconfluent focus production in cultures of MCF-7 breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Breast Cancer Res. 12, 227-233.
16. Gierthy, J. F., Lincoln, D. W., Gillespie, M. B., Seeger, J. I., Martinez, H. L., Dickerman, H. W., and Kumar, S. A. (1987). Suppression of estrogen-regulated extracellular plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 47, 6198-6203.
17. Gierthy, J. F., Bennett, J. A., Bradley, L. M., and Cutler, D. S. (1993). Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 53, 3149-3153.
18. Goldstein, J. A., and Safe, S. (1989). Mechanism of action and structure-activity relationships for the chlorinated dibenzo-p-dioxins and related compounds. In Halogenated Biphenyls, Naphthalenes, Dibenzodioxins and Related Compounds (R. D. Kimbrough and A. A. Jensen, Eds.), pp. 239-293. Elsevier-North Holland, Amsterdam.
19. Gullick, W. J. (1990). Growth factors and oncogenes in breast cancer. Prog. Growth Factor Res. 2, 1-13.
20. Harper, N., Wang, X., Liu, H., and Safe, S. (1994). Inhibition of estrogeninduced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol. Cell. Endocrinol. 104, 47-55.
21. Harns, M., Zacharewski, T., and Safe, S. (1990). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells. Cancer Res. 50, 3579-3584.
22. Hatada, E. N., McClain, D. A., Potter, E., Ullrich, A., and Olefsky, J. M. (1989). Effects of growth and insulin treatment on the levels of insulin receptors and their mRNA in HEP G2 cells. J. Biol. Chem. 264, 6741-6747.
23. Huff, K. K., Kaufman, D., Gabbay, K. H., Spencer, E. M., Lippman, M. E., and Dickson, R. B. (1986). Human breast cancer cells secrete an insulin-like growth factor I-related polypeptide. Cancer Res. 46, 4613-4619.
24. Huff, K. K., Knabbe, C., Lindsey, R., Kaufman, D., Bronzert, D., Lippman, M. E., and Dickson, R. B. (1988). Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol. Endocrinol. 2, 200-208.
25. Kasuga, M., Karlsson, F. A., and Kahn, C. R. (1982). Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215, 185-187.
26. Klotz, D. M., Castles, C. G., Fuqua, S. A., Spriggs, L. L., and Hill, S. M. (1995). Differential expression of wild-type and variant ER mRNAs by stocks of MCF-7 breast cancer cells may account for differences in estrogen responsiveness. Biochem. Biophys. Res. Commun. 210, 609-615.
27. Kosmakos, F. C., and Roth, J. (1980). Insulin-induced loss of the insulin receptor in IM-9 lymphocytes. J. Biol. Chem. 255, 9860-9869.
28. Krishnan, V., and Safe, S. (1993). Polychlormated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: Quantitative structure - activity relationships. Toxicol. Appl. Pharmacol. 120, 55-61.
29. Krishnan, V., Narasimhan, T. R., and Safe, S. (1992). Development of gel staining techniques for detecting the secretion of procathepsin D (52-kDa protein) in MCF-7 human breast cancer cells. Anal. Biochem. 204, 137-142.
30. Levy, J. R., and Hug, V. (1992). Regulation of insulin receptor gene expression: Cell cycle-mediated effects on insulin receptor mRNA stability. J. Biol. Chem. 267, 25289-25295.
31. Li, X., Chen, J., Sheikh, M. S., Shao, Z., and Fontana, J. A. (1994). Retinoic acid inhibition of insulin-like growth factor I stimulation of c-fos mRNA levels in a breast carcinoma cell line. Exp. Cell Res. 211, 68-73.
32. Lippman, M. E., Huff, K. K., Jakesz, R., Hecht, T., Kasid, A., Bates, S., and Dickson, R. B. (1986). Estrogens regulate production of specific growth factors in hormone-dependent human breast cancer. In Estrogen/ Antiestrogen Action and Breast Cancer Therapy (C. V. Jordan, Ed.), pp. 237-247. Univ. Wisconsin Press, Madison, WI.
33. Liu, H., Biegel, L., Narasimhan, T. R., Rowlands, C., and Safe, S. (1992). Inhibition of insulin-like growth factor-I responses in MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Mol. Cell. Endocrinol. 87, 19-28.
34. Lusska, A., Shen, E., and Whitlock, J. P., Jr. (1993). Protein-DNA interactions at a dioxin-responsive enhancer: Analysis of six bona fide DNA-binding sites for the liganded Ah receptor. J. Biol. Chem. 268, 6575-6580.
35. Ma, X., Mufti, N. A., and Babish, J. G. (1992). Protein tyrosine phosphorylation as an indicator of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure in vivo and in vitro. Biochem. Biophys. Res. Commun. 189, 59-65.
36. cdc2 kinase by 2,3,7,8-tetrachlorodibenzo-p-dioxin is mediated through the Ah receptor. Toxicologist 14, 410.
37. Mason, G., Sawyer, T., Keys, B., Bandiera, S., Romkes, M., Piskorska-Pliszczynska, Zmndzka, B., and Safe, S. (1986). Polychlorinated dibenzofurans (PCDFs): Correlation between in vivo and in vitro structure-activity relationships. Toxicology 37, 1-12.
38. Merchant, M., Krishnan, V., and Safe, S. (1993). Mechanism of action of α-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Toxicol. Appl. Pharmacol. 120, 179-185.
39. Milazzo, G., Giorgino, F., Damante, G., Sung, C., Stampfer, M. R., Vigneri, R., Goldfine, I. D., and Belfiore, A. (1992a). Insulin receptor expression and function in human breast cancer cell lines. Cancer Res. 52, 3924-3930.
40. Milazzo, G., Yip, C. C., Maddux, B. A., Vigneri, R., and Goldfine, I. D. (1992b). High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells. J. Clin. Invest. 89, 899-908.
41. 13C-nuclear magnetic resonance studies. Mol. Pharmacol. 40, 1029-1035.
42. Noguchi, M., Thomas, M., Koyasaki, N., Ohta, N., Taniya, T., and Kitagawa, H. (1993). Influence of hormones on tumor growth, cell kinetics, estrogen receptor and insulin-like growth factor-I-related protein of human breast cancer (MCF-7) cells transplanted in nude mice. Mol. Cell. Endocrinol. 92, 69-76.
43. Okey, A. B., Riddick, D. S., and Harper, P. A. (1994). The Ah receptor: Mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 70, 1-22.
44. Osborne, C. K., Bolan, G. B., Monaco, M. E., and Lippman, M. E. (1976). Hormone responsive human breast cancer in long-term tissue culture: Effect of insulin. Proc. Natl. Acad. Sci. USA 73, 4536-4540.
45. Osborne, C. K., Clemmons, D. R., and Arteaga, C. L. (1990). Regulation of breast cancer growth by insulin-like growth factors. J. Steroid Biochem. Mol. Biol. 37, 805-809.
46. Osborne, C. K., Monaco, M. E., Lippman, M. E., and Kahn, C. R. (1978). Correlation among insulin binding degradation and biological activity in human breast cancer cells in long-term culture. Cancer Res. 38, 94-102.
47. Papa, V., Pezzino, V., Costantino, A., Belfiore, A. D. G. L. F., Vannelli, G. B., Brand, R., Goldfine, I. D., and Vigneri, R. (1990a). Elevated insulin receptor content in human breast cancer. J. Clin. Invest. 85, 1503-1510.
48. Papa, V., Reese, C. C., Brunetti, A., Vigneri, R., Siiteri, P. K., and Goldfine, I. D. (1990b). Progestins increase insulin receptor content and stimulation of growth in human breast carcinoma cells. Cancer Res. 50, 7858-7862.
49. Phillips, A., Chalbos, D., and Rochefort, H. (1993). Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF-7 breast cancer cells without affecting c-fos and c-jun synthesis. J. Biol. Chem. 268, 14105-14108.
50. Poland, A., and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons. Examinations of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554.
51. Puga, A., Nebert, D. W., and Carrier, F. (1992). Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 11, 269-281.
52. Romkes, M., and Safe, S. (1988). Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and progesterone on antiestrogens in the female rat uterus. Toxicol. Appl. Pharmacol. 92, 368-380.
53. Romkes, M., Piskorska-Pliszczynska, J., and Safe, S. (1987). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic and uterine estrogen receptor levels in rats. Toxicol. Appl. Pharmacol. 87, 306-314.
54. Rozengurt, E., Sinnett-Smith, J., and Taylor-Papadimitriou, J. (1985). Production of PDGF-like growth factor by breast cancer cell lines. Int. J. Cancer 36, 246-252.
55. Safe, S. (1986). Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol. 26, 371-399.
56. Safe, S. (1995). Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther. 67, 247-281.
57. Safe, S., Astroff, B., Harris, M., Zacharewski, T., Dickerson, R., Romkes, M., and Biegel, L. (1991). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antiestrogens: Characterization and mechanism of action. Pharmacol. Toxicol. 69, 400-409.
58. Sambrook, J., Fritsch, E., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
59. Semo, S., Seino, M., Nishi, S., and Bell, G. (1989). Structure of the human insulin receptor gene and characterization. Proc. Natl. Acad. Sci. USA 86, 114-118.
60. Skonik, E. Y., Lee, C. H., Batzer, A. G., Vicentini, L. M., Zhou, M., Daly, R. J., Myers, M. G. J., Backer, J. M., Ullrich, A., White, M. F., and Schlessinger, J. (1993). The SH2/SH3 somain containing protein GRB2 interacts with tyrosine phosphorylated IRS-1 and SHC: implications for insulin control of ras signaling. EMBO J. 12, 1929-1936.
61. Snyder, N. K., Kramer, C. M., Dooley, R. K., and Holsapple, M. P. (1993). Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity. Drug Chem. Toxicol. 16, 135-163.
62. Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M, Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., and White, M. F. (1991). The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77.
63. Sun, X. J., Crimmins, D. L., Myers, M. G., Jr., Miralpeix, M., and White, M. F. (1993). Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 3, 7418-7428.
64. Swanson, H. I., and Bradfield, C. A. (1993). The Ah-receptor: Genetics, structure and function. Pharmacogenetics 3, 213-223.
65. Tewari, D. S., Cook, D. M., and Taub, R. (1989). Characterization of the promoter region and 3′ end of the human insulin receptor gene. J. Biol. Chem. 264, 16238-16245.
66. van der Burg, B., Rutteman, B., Blankenstein, G. R., De Laat, S. W., and Van Zoelen, E. J. J. (1988). Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: Synergistic action of insulin and estrogen. J. Cell. Physiol. 134, 101-108.
67. van der Burg, B., Van Selm-Miltenburg, A. J. P., De Laat, S. W., and Van Zoelen, E. J. J. (1989). Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol. Cell. Endocrinol. 64, 223-228.
68. van der Burg, B., De Groot, R. P., Isbrücker, L., Kruijer, W., and De Laat, S. W. (1990). Stimulation of TPA-responsive element activity by a cooperative action of insulin and estrogen in human breast cancer cells. Mol. Endocrinol. 4, 1720-1726.
69. van der Burg, B., De Groot, R. P., Isbrucker, L., Kruijer, W., and De Laat, S. W. (1991). Oestrogen directly stimulates growth factor signal transduction pathways in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 40, 215-221.
70. van Roozendaal, C. E. P., Van Ooijen, B., Klijn, J. G. M., Claassen, C., Eggermont, A. M. M., Henzen-Logmans, S. C., and Foekens, J. A. (1992). Stromal influences on breast cancer cell growth. Br. J. Cancer 65, 77-81.
71. Vigneri, R., and Goldfine, I. D. (1993). In Oncogenes and Tumor Suppressor Genes in Human Malignancies (C. C. Benz and E. T. Liu, Eds.), pp. 193-209. Kluwer Academic, Boston.
72. Vignon, F., Capony, F., Chambon, M., Freiss, G., Garcia, M., and Rochefort, H. (1986). Autocrine growth stimulation of the MCF-7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology 118, 1537-1545.
73. Wang, S. L., Lucier, G. W., Everson, R. G., Sunahara, G. I., and Shiverick, K. T. (1989). Smoking-related alterations in epi dermal growth factor and insulin receptors in human placenta. Mol. Pharmacol. 34, 265-271.
74. Weisz, A., and Bresciani, F. (1993). Estrogen regulation of proto-oncogenes coding for nuclear proteins. Crit. Rev. Oncog. 4, 361-388.
75. White, M. F., Maron, R., and Kahn, O. R (1985). Insulin rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells. Nature 318, 183-186.
76. Whitlock, J. P., Jr. (1993). Mechanistic aspects of dioxin action. Chem. Res. Toxicol. 6, 754-763.
77. Wilding, G., Lippman, M. E., and Gelmann, E. P. (1988). Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. Cancer Res. 48, 802-805.
78. Wosikowski, K., Küng, W., Hasmann, M., Löser, R., and Eppenberger, U. (1993). Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells. Int. J. Cancer 43, 290-297.
79. Yarden, Y., and Ullrich, A. (1988). Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 57, 443-478.